4
Changes in Ownership
CAPRICOR THERAPEUTICS, INC. Filed Acc 0001104659-20-022105
Options or other derivatives
- CHIEF EXECUTIVE OFFICER acquired 121,494 shares (grant or award)
- CHIEF EXECUTIVE OFFICER returned 121,494 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Marban Linda CHIEF EXECUTIVE OFFICER | 2020-02-12 | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | D | ||
| Marban Linda CHIEF EXECUTIVE OFFICER | 2020-02-12 | Grant or award · Stock Option (Right to Buy) | +9,998 | 9,998 | D | ||
| Marban Linda CHIEF EXECUTIVE OFFICER | 2020-02-12 | Grant or award · Stock Option (Right to Buy) | +19,999 | 19,999 | D | ||
| Marban Linda CHIEF EXECUTIVE OFFICER | 2020-02-12 | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | D | ||
| Marban Linda CHIEF EXECUTIVE OFFICER | 2020-02-12 | Grant or award · Stock Option (Right to Buy) | +41,497 | 41,497 | D | ||
| Marban Linda CHIEF EXECUTIVE OFFICER | 2020-02-12 | Returned to the company · Stock Option (Right to Buy) | −25,000 | 0 | D | ||
| Marban Linda CHIEF EXECUTIVE OFFICER | 2020-02-12 | Returned to the company · Stock Option (Right to Buy) | −9,998 | 0 | D | ||
| Marban Linda CHIEF EXECUTIVE OFFICER | 2020-02-12 | Returned to the company · Stock Option (Right to Buy) | −19,999 | 0 | D | ||
| Marban Linda CHIEF EXECUTIVE OFFICER | 2020-02-12 | Returned to the company · Stock Option (Right to Buy) | −25,000 | 0 | D | ||
| Marban Linda CHIEF EXECUTIVE OFFICER | 2020-02-12 | Returned to the company · Stock Option (Right to Buy) | −41,497 | 0 | D | ||
Loading xslF345X03/tm208086d8_4.xml…